358 related articles for article (PubMed ID: 34003768)
1. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect.
Baruch EN; Wang J; Wargo JA
Cancer Immunol Res; 2021 Apr; 9(4):365-370. PubMed ID: 34003768
[TBL] [Abstract][Full Text] [Related]
2. The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy.
Qi X; Liu Y; Hussein S; Choi G; Kimchi ET; Staveley-O'Carroll KF; Li G
Cells; 2022 Nov; 11(22):. PubMed ID: 36429112
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
4. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota in Cancer Immune Response and Immunotherapy.
Zhou CB; Zhou YL; Fang JY
Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.
Di Modica M; Gargari G; Regondi V; Bonizzi A; Arioli S; Belmonte B; De Cecco L; Fasano E; Bianchi F; Bertolotti A; Tripodo C; Villani L; Corsi F; Guglielmetti S; Balsari A; Triulzi T; Tagliabue E
Cancer Res; 2021 Apr; 81(8):2195-2206. PubMed ID: 33483370
[TBL] [Abstract][Full Text] [Related]
8. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
9. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota: a potential target for improved cancer therapy.
Zhao M; Jiang G; Zhou H; Li J; Xiang W; Li S; Wang H; Zhou J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):541-552. PubMed ID: 36550389
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cancer immunotherapy efficacy by gut microbiota.
Huo S; Liu L; Liu J; Li Q; Wang J
Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.
Uribe-Herranz M; Bittinger K; Rafail S; Guedan S; Pierini S; Tanes C; Ganetsky A; Morgan MA; Gill S; Tanyi JL; Bushman FD; June CH; Facciabene A
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467322
[TBL] [Abstract][Full Text] [Related]
16. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
17. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F
Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.
Guven DC; Aktas BY; Simsek C; Aksoy S
Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
